Diabetes Might Augment the Severity of COVID-19: A Current Prospects

Diabetes Might Augment the Severity of COVID-19: A Current Prospects

Bibliographic Details
Main Authors:	Jayeeta Sur, Juhi Sharma, Divakar Sharma
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2021-01-01
Series:	Frontiers in Cardiovascular Medicine
Subjects:	diabetes COVID-19 SARS-CoV-2 hyperglyceamia ACE2
Online Access:	https://www.frontiersin.org/articles/10.3389/fcvm.2020.613255/full

Similar Items

Should we use angiotensin II infusion in COVID-19-associated vasoplegic shock?
by: Karim Bendjelid
Published: (2020-07-01)

Severity of COVID-19: The importance of being hypertensive
by: Fabio Angeli, et al.
Published: (2020-05-01)

Genetics Insight for COVID-19 Susceptibility and Severity: A Review
by: Ingrid Fricke-Galindo, et al.
Published: (2021-04-01)

COVID-19 and RAS: Unravelling an Unclear Relationship
by: Damiano D’Ardes, et al.
Published: (2020-04-01)

COVID-19 and Individual Genetic Susceptibility/Receptivity: Role of ACE1/ACE2 Genes, Immunity, Inflammation and Coagulation. Might the Double X-chromosome in Females Be Protective against SARS-CoV-2 Compared to the Single X-Chromosome in Males?
by: Donato Gemmati, et al.
Published: (2020-05-01)

The Impact of Angiotensin-Converting Enzyme 2 (ACE2) Expression on the Incidence and Severity of COVID-19 Infection
by: Ahmed O. Kaseb, et al.
Published: (2021-03-01)

Current Perspectives in the Discovery of Newer Medications Against the Outbreak of COVID-19
by: M. Ramesh, et al.
Published: (2021-07-01)

Molecular and Biological Mechanisms Underlying Gender Differences in COVID-19 Severity and Mortality
by: Zena Wehbe, et al.
Published: (2021-05-01)

SARS-CoV-2 Infection Modulates ACE2 Function and Subsequent Inflammatory Responses in Swabs and Plasma of COVID-19 Patients
by: Lucía Gutiérrez-Chamorro, et al.
Published: (2021-08-01)

Male predisposition to severe COVID-19: Review of evidence and potential therapeutic prospects
by: Desmond Omane Acheampong, et al.
Published: (2020-11-01)

The Role of Glutathione in Protecting against the Severe Inflammatory Response Triggered by COVID-19
by: Francesca Silvagno, et al.
Published: (2020-07-01)

Repurposing existing drugs for COVID-19: an endocrinology perspective
by: Flavio A. Cadegiani
Published: (2020-09-01)

SARS-CoV-2 Cellular Entry Is Independent of the ACE2 Cytoplasmic Domain Signaling
by: Thankamani Karthika, et al.
Published: (2021-07-01)

COVID-19
by: Xiajun Li, et al.
Published: (2021-08-01)

Potential harmful effects of discontinuing ACE-inhibitors and ARBs in COVID-19 patients
by: Gian Paolo Rossi, et al.
Published: (2020-04-01)

Considerations for target oxygen saturation in COVID-19 patients: are we under-shooting?
by: Niraj Shenoy, et al.
Published: (2020-08-01)

Molecular Mechanisms Lead to Sex-Specific COVID-19 Prognosis and Targeted Therapies
by: Thushara Galbadage, et al.
Published: (2020-12-01)

Curcumin as a Potential Treatment for COVID-19
by: Bruna A. C. Rattis, et al.
Published: (2021-05-01)

Sex-dependent immune response and lethality of COVID-19
by: Albert Jiarui Li, et al.
Published: (2021-01-01)

Loss of Smell in COVID-19 Patients: Lessons and Opportunities
by: Dennis Mathew
Published: (2020-11-01)

Elevation of plasma angiotensin II level is a potential pathogenesis for the critically ill COVID-19 patients
by: Zhiyong Wu, et al.
Published: (2020-06-01)

The Impact of <i>Angiotensin-Converting Enzyme 2</i> (<i>ACE2</i>) Expression Levels in Patients with Comorbidities on COVID-19 Severity: A Comprehensive Review
by: Rui Rodrigues, et al.
Published: (2021-08-01)

Genetic Polymorphisms Complicate COVID-19 Therapy: Pivotal Role of HO-1 in Cytokine Storm
by: Eddie W. Fakhouri, et al.
Published: (2020-07-01)

Multi-Organ Involvement in COVID-19: Beyond Pulmonary Manifestations
by: Vikram Thakur, et al.
Published: (2021-01-01)

Dysregulation of COVID-19 related gene expression in the COPD lung
by: Alastair Watson, et al.
Published: (2021-05-01)

Main Clinical Features of COVID-19 and Potential Prognostic and Therapeutic Value of the Microbiota in SARS-CoV-2 Infections
by: Yu He, et al.
Published: (2020-06-01)

Opportunities, Challenges and Pitfalls of Using Cannabidiol as an Adjuvant Drug in COVID-19
by: Barbara Malinowska, et al.
Published: (2021-02-01)

Impact of COVID-19 on Alzheimer’s Disease Risk: Viewpoint for Research Action
by: Giulia Abate, et al.
Published: (2020-08-01)

Regulation of Angiotensin- Converting Enzyme 2 in Obesity: Implications for COVID-19
by: Saba Al Heialy, et al.
Published: (2020-09-01)

Insights to SARS-CoV-2 life cycle, pathophysiology, and rationalized treatments that target COVID-19 clinical complications
by: Ioannis P. Trougakos, et al.
Published: (2021-01-01)

Bioengineered probiotics to control SARS-CoV-2 infection
by: Shantibhusan Senapati, et al.
Published: (2020-05-01)

Role of SARS-CoV-2 and ACE2 variations in COVID-19
by: Priya Antony, et al.
Published: (2021-06-01)

The Folate Concentration and/or Folic Acid Metabolites in Plasma as Factor for COVID-19 Infection
by: Jesus Acosta-Elias, et al.
Published: (2020-07-01)

Identification of selected genes associated with the SARS-CoV-2: a therapeutic approach and disease severity
by: Ramakrishnan Veerabathiran, et al.
Published: (2021-04-01)

Current targets and drug candidates for prevention and treatment of SARS-CoV-2 (COVID-19) infection
by: Ramesh K. Goyal, Jaseela Majeed, Rajiv Tonk, Mahaveer Dhobi, Bhoomika Patel, Kalicharan Sharma, Subbu Apparsundaram
Published: (2020-09-01)

COVID-19 Pathogenesis: From Molecular Pathway to Vaccine Administration
by: Francesco Nappi, et al.
Published: (2021-07-01)

Is There a Link between Bisphenol A (BPA), a Key Endocrine Disruptor, and the Risk for SARS-CoV-2 Infection and Severe COVID-19?
by: Aeman Zahra, et al.
Published: (2020-10-01)

Smoking Is Correlated With the Prognosis of Coronavirus Disease 2019 (COVID-19) Patients: An Observational Study
by: Fei Peng, et al.
Published: (2021-03-01)

Potential pharmacological approach in the regulation of ACE-2 and DPP-IV in diabetic COVID-19 patient
by: Francesco Ferrara, et al.
Published: (2020-12-01)

Pausing the Fight Against Malaria to Combat the COVID-19 Pandemic in Africa: Is the Future of Malaria Bleak?
by: Nora Nganyewo Nghochuzie, et al.
Published: (2020-06-01)